Yi-Bin Chen, MD

Articles

Emerging Strategies for the Treatment of Acute GVHD

April 6th 2023

Sophie Paczesny, MD, PhD, and Yi-Bin Chen, MD, detail novel strategies under investigation for the treatment of acute GVHD.

Frontline Treatment Options for Acute GVHD

April 6th 2023

Experts discuss the current options for treating acute GVHD, including the use of corticosteroids and their management.

Diagnosis and Stratification of Acute and Chronic GVHD

March 31st 2023

Drs Yi-Bin Chen and Sophie Paczesny review the diagnosis and staging of both acute and chronic GVHD, and the challenges clinicians may encounter.

Common Prophylaxis Regimens for GVHD

March 31st 2023

Yi-Bin Chen, MD, shares the most common GVHD prophylaxis regimens, and which regimen he typically chooses for his patients with GVHD.

Incidence and Risk Factors of Acute and Chronic GVHD

March 23rd 2023

Dr Sophie Paczesny details the incidence of graft versus host disease (GVHD) in patients receiving allogeneic transplants, and Dr Yi-Bin Chen describes the differing risk factors for acute and chronic GVHD.

Indications for Allogeneic Stem Cell Transplantation in the Treatment of Hematological Malignancies

March 23rd 2023

Sophie Paczesny, MD, PhD, explains which malignancies allogeneic transplantation can be used as a potentially curative treatment approach, and which patients are best suited for transplant.

Dr. Chen on the Efficacy of Vedolizumab Prophylaxis for aGVHD in the GRAPHITE Trial

March 1st 2023

Yi-Bin Chen, MD, discusses key data on the use of vedolizumab in lower gastrointestinal acute Graft-Versus-Host Disease according to the phase 3 GRAPHITE study.

GvHD: Advice for Patients

February 17th 2023

Experts share their insights and advice on how to best communicate with patients who are actively dealing with acute or chronic GvHD.

Future of Chronic GvHD

February 17th 2023

A look into the future of chronic GvHD and which treatment options patients the panel is most excited about.

Treatment Options: Steroid-Refractory GvHD

February 10th 2023

Experts define and review treatment options for patients with chronic GvHD that are also steroid refractory.

Treatment Options for Chronic GvHD

February 10th 2023

Comprehensive discussion into the available treatment options for patients that present with chronic GvHD.

Defining Chronic Graft vs Host Disease (GvHD)

February 3rd 2023

Panel of oncologists define in chronic GvHD and review the typical presentation of a patient.

Novel Agents in Acute GvHD

February 3rd 2023

Experts discuss new and exciting agents and combinations that are on the horizon for patients with acute GvHD.

Steroid Refractory Acute GvHD and REACH Trials

January 27th 2023

An overview of steroid refractory acute GvHD and a review of the REACH trials that assessed the used of ruxolitinib in patients with GvHD.

Acute GvHD: Clinical Presentation, Risk Factors and Treatment Options

January 27th 2023

Experts discuss the clinical presentation, grading system and review treatment options for patients with acute GvHD.

Future of Acute GvHD Prevention

January 20th 2023

A look into the future of acute GvHD prevention and discussing the impact of targeting specific organs to help manage GvHD prevention.

Clinical Implications of the Phase III BMT CTN 1703 Trial

January 20th 2023

Experts review the Phase III BMT CTN 1703 trial and share how the results of this trial might impact their practice and discuss the role of ATG and abatacept in their practice

Regimens Used for GvHD Prevention

January 13th 2023

A brief review of the different regimens used by experts for GvHD prevention at their institutions and discuss the importance of GvHD Prevention.

An Overview of Graft vs Host Disease (GvHD)

January 13th 2023

Expert oncologists define graft vs host disease (GvHD) and discuss which risk factors might increase a patient’s risk of developing GvHD.

Using Multidisciplinary Care to Optimize Outcomes in GVHD

August 29th 2022

Sharing closing thoughts on acute and chronic GVHD management, expert panelists first consider the value of multidisciplinary care.